ACVR2A and metabolic dysfunction-associated steatohepatitis: A recent study found higher mutation rates in the gene encoding activin A receptor type 2A among patients with nonalcoholic steatohepatitis (NASH)-associated HCC than among patients with HCC due to other etiologies (10% vs. 3%, p<0.05).